首页> 外文期刊>Medicine. >Langerhans cell sarcoma arising from antecedent langerhans cell histiocytosis: A case report
【24h】

Langerhans cell sarcoma arising from antecedent langerhans cell histiocytosis: A case report

机译:朗格汉斯细胞组织细胞增生症引起的朗格汉斯细胞肉瘤:1例

获取原文
           

摘要

Rationale: Langerhans cell sarcoma (LCS) is a rare, high-grade neoplasm characterized by overtly malignant cytologic features and a poor prognosis. Herein, we present a rare case of langerhans cell histiocytosis (LCH) that later transformed into langerhans cell sarcoma 11 months after the benign mass was excised from soft tissue in the right groin. Patient concerns: A 41-year-old patient who presented with a mass in the right groin for 3 years earlier after being bitten by ants. Diagnoses: The patient was diagnosed with langerhans cell sarcoma arising from antecedent langerhans cell histiocytosis. Interventions: The patient underwent with 6 cycles of a modified etoposide, cyclophosphamide, vindesine, dexamethasone (E-CHOP) regimen. Outcomes: The patient is currently receiving follow-up care. Lessons: LCH transformed into LCS is a rare case. E-CHOP as an effective first-line therapy to treat LCS cases, but, the mechanism is unclear. Due to their rarity, further data on clinical outcomes are necessary to establish the optimal treatment strategy for LCS.
机译:理由:郎格罕斯细胞肉瘤(LCS)是一种罕见的高级别肿瘤,其特征是明显的恶性细胞学特征和预后不良。在此,我们介绍了罕见的朗格汉斯细胞组织细胞增生症(LCH),在良性肿块从右腹股沟的软组织上切除11个月后,其转变为朗格汉斯细胞肉瘤。患者担忧:一名41岁的患者,在被蚂蚁咬伤后的3年内出现了右腹股沟肿块。诊断:该患者被诊断出患有由先前的朗格汉斯细胞组织细胞增生症引起的朗格汉斯细胞肉瘤。干预措施:该患者接受了6个周期的改良依托泊苷,环磷酰胺,长春地辛,地塞米松(E-CHOP)方案治疗。结果:患者目前正在接受后续护理。经验教训:将LCH转换为LCS的情况很少。 E-CHOP是治疗LCS的有效一线治疗方法,但其机制尚不清楚。由于它们的稀有性,因此需要进一步的临床结果数据以建立LCS的最佳治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号